Revvity (RVTY) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Revvity (RVTY) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -35.32% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 50.05% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 58.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 29.57% |
| Apr 5, 2026 | -26.47% |
| Dec 28, 2025 | 59.20% |
| Mar 30, 2025 | -34.48% |
| Sep 29, 2024 | 51.43% |
| Jun 30, 2024 | 45.29% |
| Mar 31, 2024 | -45.37% |
| Dec 31, 2023 | -34.20% |
| Oct 1, 2023 | -96.62% |
| Jul 2, 2023 | -270.72% |
| Apr 2, 2023 | 413.75% |
| Jan 1, 2023 | 24.60% |
| Apr 3, 2022 | 77.38% |
| Oct 3, 2021 | -212.13% |
| Jul 4, 2021 | -204.47% |
| Apr 4, 2021 | 194.65% |
| Jan 3, 2021 | 29.11% |
| Oct 4, 2020 | -29.21% |
| Jul 5, 2020 | -60.70% |
| Apr 5, 2020 | 28.98% |